SEC Form 4 · accession 0001179110-18-002675
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theresa Wingrove
Officer — VP of Regulatory Affairs
Period of report
Feb 21, 2018
Accepted (ET)
Feb 23, 2018 · 11:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Feb 21, 2018 | S | 11,379 | $10.88 | D | 90,671 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average price of shares sold.
- F2The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.